283 related articles for article (PubMed ID: 18434932)
1. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
[TBL] [Abstract][Full Text] [Related]
2. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
[TBL] [Abstract][Full Text] [Related]
3. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
4. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Schwartz E; Bujanover S; Kain KC
Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
[TBL] [Abstract][Full Text] [Related]
5. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
[TBL] [Abstract][Full Text] [Related]
6. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Kuhn S; Gill MJ; Kain KC
Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
[TBL] [Abstract][Full Text] [Related]
8. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
Musset L; Le Bras J; Clain J
Mol Biol Evol; 2007 Aug; 24(8):1582-5. PubMed ID: 17488741
[TBL] [Abstract][Full Text] [Related]
9. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
[No Abstract] [Full Text] [Related]
10. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum outwits Malarone, protector of travellers.
Crabb C
Bull World Health Organ; 2003; 81(5):382-3. PubMed ID: 12856058
[No Abstract] [Full Text] [Related]
12. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
[TBL] [Abstract][Full Text] [Related]
13. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
14. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
15. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Thapar MM; Gil JP; Björkman A
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone/proguanil resistance in Africa: a case report.
David KP; Alifrangis M; Salanti A; Vestergaard LS; Rønn A; Bygbjerg IB
Scand J Infect Dis; 2003; 35(11-12):897-8. PubMed ID: 14723376
[TBL] [Abstract][Full Text] [Related]
18. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
Patel SN; Kain KC
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
Berry A; Senescau A; Lelièvre J; Benoit-Vical F; Fabre R; Marchou B; Magnaval JF
Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):986-8. PubMed ID: 16690094
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
